| HGNC Family | Basic leucine zipper proteins |
| Name | nuclear factor, erythroid 2-like 2 |
| Description | This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals. Multiple transcript variants encoding different isoforms have been characterized for this gene. [provided by RefSeq, Sep 2015] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNuclear factor erythroid 2–related factor 2 (Nrf2) is a master redox‐sensitive transcription factor that orchestrates cellular defense against oxidative and electrophilic stress by inducing a wide array of cytoprotective genes. Under normal conditions, Nrf2 is sequestered in the cytoplasm by its inhibitor Keap1, which targets it for ubiquitin‑mediated proteasomal degradation. In response to cellular stress, electrophilic modification of Keap1 and other post‐translational events (such as phosphorylation and acetylation) permit Nrf2 stabilization and nuclear translocation, where it binds to antioxidant response elements (AREs) and promotes the transcription of detoxification, phase II metabolism, and antioxidant genes to reestablish redox homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its canonical role in mediating antioxidant and detoxification responses, Nrf2 integrates signals from diverse cellular pathways to influence metabolism, autophagy, and cell survival. Interactions with adaptor proteins (such as p62) and regulatory kinases like glycogen synthase kinase‑3β and AMP‑activated protein kinase modulate its nuclear localization and transcriptional output. These mechanisms, which also affect metabolic reprogramming (including regulation of serine/glycine biosynthesis) and drug efflux, contribute to chemoresistance and enhanced cellular proliferation when Nrf2 is aberrantly activated—in many cancers, for instance, constitutive Nrf2 activity confers resistance to apoptosis and promotes tumor growth."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe dualistic nature of Nrf2 presents significant therapeutic implications. While activation of the Nrf2 pathway can protect normal tissues from oxidative injury, inflammation, and metabolic dysfunction (as in diabetic nephropathy and other chronic conditions), its persistent or deregulated activation in cancer cells can drive chemoresistance, metastasis, and even alter cell fate decisions such as ferroptosis. Emerging strategies aim either to inhibit Nrf2 in tumors to overcome drug resistance or to activate it in degenerative and age‐related diseases—in conditions as diverse as progeria and cardiac insulin resistance—to restore cellular homeostasis. This fine balance underscores the broad impact of Nrf2 on human health and the promise of targeted interventions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "34", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Truyen Nguyen, Philip J Sherratt, H-C Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M207293200"}], "href": "https://doi.org/10.1074/jbc.M207293200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12446695"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12446695"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "David A Bloom, Anil K Jaiswal "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M307633200"}], "href": "https://doi.org/10.1074/jbc.M307633200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12947090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12947090"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Akira Kobayashi, Moon-Il Kang, Hiromi Okawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.24.16.7130-7139.2004"}], "href": "https://doi.org/10.1128/MCB.24.16.7130-7139.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15282312"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15282312"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Manabu Furukawa, Yue Xiong "}, {"type": "b", "children": [{"type": "t", "text": "BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.25.1.162-171.2005"}], "href": "https://doi.org/10.1128/MCB.25.1.162-171.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15601839"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15601839"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xi-Lin Chen, Geraldine Dodd, Suzanne Thomas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Heart Circ Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpheart.00651.2005"}], "href": "https://doi.org/10.1152/ajpheart.00651.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16339837"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16339837"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Balasundaram Padmanabhan, Kit I Tong, Tsutomu Ohta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2006.01.013"}], "href": "https://doi.org/10.1016/j.molcel.2006.01.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16507366"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16507366"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Anju Singh, Vikas Misra, Rajesh K Thimmulappa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Med (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pmed.0030420"}], "href": "https://doi.org/10.1371/journal.pmed.0030420"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17020408"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17020408"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Donna D Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Mechanistic studies of the Nrf2-Keap1 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Rev (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/03602530600971974"}], "href": "https://doi.org/10.1080/03602530600971974"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17145701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17145701"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Tsutomu Ohta, Kumiko Iijima, Mamiko Miyamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-07-5003"}], "href": "https://doi.org/10.1158/0008-5472.CAN-07-5003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18316592"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18316592"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xiao-Jun Wang, Zheng Sun, Nicole F Villeneuve, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgn095"}], "href": "https://doi.org/10.1093/carcin/bgn095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18413364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18413364"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Anju Singh, Swetlana Boldin-Adamsky, Rajesh K Thimmulappa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-1401"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-1401"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18829555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18829555"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Alexandria Lau, Nicole F Villeneuve, Zheng Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual roles of Nrf2 in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacol Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.phrs.2008.09.003"}], "href": "https://doi.org/10.1016/j.phrs.2008.09.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18838122"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18838122"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Truyen Nguyen, Paul Nioi, Cecil B Pickett "}, {"type": "b", "children": [{"type": "t", "text": "The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.R900010200"}], "href": "https://doi.org/10.1074/jbc.R900010200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19182219"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19182219"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Zheng Sun, Y Eugene Chin, Donna D Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01639-08"}], "href": "https://doi.org/10.1128/MCB.01639-08"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19273602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19273602"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "John D Hayes, Michael McMahon "}, {"type": "b", "children": [{"type": "t", "text": "NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Trends Biochem Sci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.tibs.2008.12.008"}], "href": "https://doi.org/10.1016/j.tibs.2008.12.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19321346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19321346"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yoo Ri Kim, Ji Eun Oh, Min Sung Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.2653"}], "href": "https://doi.org/10.1002/path.2653"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19967722"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19967722"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Tao Jiang, Zheping Huang, Yifeng Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db09-1342"}], "href": "https://doi.org/10.2337/db09-1342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20103708"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20103708"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Alexandria Lau, Xiao-Jun Wang, Fei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00248-10"}], "href": "https://doi.org/10.1128/MCB.00248-10"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20421418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20421418"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Ashish Jain, Trond Lamark, Eva Sjøttem, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.118976"}], "href": "https://doi.org/10.1074/jbc.M110.118976"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20452972"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20452972"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Luisa M Solis, Carmen Behrens, Wenli Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-09-3352"}], "href": "https://doi.org/10.1158/1078-0432.CCR-09-3352"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20534738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20534738"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Dongmei Ren, Nicole F Villeneuve, Tao Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1014275108"}], "href": "https://doi.org/10.1073/pnas.1014275108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21205897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21205897"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Keiko Taguchi, Hozumi Motohashi, Masayuki Yamamoto "}, {"type": "b", "children": [{"type": "t", "text": "Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Cells (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2443.2010.01473.x"}], "href": "https://doi.org/10.1111/j.1365-2443.2010.01473.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21251164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21251164"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yi Tan, Tomonaga Ichikawa, Jinqing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db10-1164"}], "href": "https://doi.org/10.2337/db10-1164"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21270272"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21270272"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yoshihiro Inami, Satoshi Waguri, Ayako Sakamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.201102031"}], "href": "https://doi.org/10.1083/jcb.201102031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21482715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21482715"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Gina M DeNicola, Florian A Karreth, Timothy J Humpton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature10189"}], "href": "https://doi.org/10.1038/nature10189"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21734707"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21734707"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "S Chowdhry, Y Zhang, M McMahon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.388"}], "href": "https://doi.org/10.1038/onc.2012.388"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22964642"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22964642"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Suryakant K Niture, Raju Khatri, Anil K Jaiswal "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of Nrf2-an update."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2013.02.008"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2013.02.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23434765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23434765"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Louise Hecker, Naomi J Logsdon, Deepali Kurundkar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Transl Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scitranslmed.3008182"}], "href": "https://doi.org/10.1126/scitranslmed.3008182"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24718857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24718857"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Cristina Espinosa-Diez, Verónica Miguel, Daniela Mennerich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antioxidant responses and cellular adjustments to oxidative stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Redox Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.redox.2015.07.008"}], "href": "https://doi.org/10.1016/j.redox.2015.07.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26233704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26233704"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Ying Huang, Wenji Li, Zheng-yuan Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The complexity of the Nrf2 pathway: beyond the antioxidant response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Nutr Biochem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jnutbio.2015.08.001"}], "href": "https://doi.org/10.1016/j.jnutbio.2015.08.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26419687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26419687"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Gina M DeNicola, Pei-Hsuan Chen, Edouard Mullarky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NRF2 regulates serine biosynthesis in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.3421"}], "href": "https://doi.org/10.1038/ng.3421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26482881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26482881"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Joanna D Wardyn, Amy H Ponsford, Christopher M Sanderson "}, {"type": "b", "children": [{"type": "t", "text": "Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Soc Trans (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BST20150014"}], "href": "https://doi.org/10.1042/BST20150014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26551702"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26551702"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Min Sung Joo, Won Dong Kim, Ki Young Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00118-16"}], "href": "https://doi.org/10.1128/MCB.00118-16"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27161318"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27161318"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Nard Kubben, Weiqi Zhang, Lixia Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Repression of the Antioxidant NRF2 Pathway in Premature Aging."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2016.05.017"}], "href": "https://doi.org/10.1016/j.cell.2016.05.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27259148"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27259148"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Silvia Menegon, Amedeo Columbano, Silvia Giordano "}, {"type": "b", "children": [{"type": "t", "text": "The Dual Roles of NRF2 in Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Trends Mol Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molmed.2016.05.002"}], "href": "https://doi.org/10.1016/j.molmed.2016.05.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27263465"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27263465"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Claudia Tonelli, Iok In Christine Chio, David A Tuveson "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional Regulation by Nrf2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Antioxid Redox Signal (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/ars.2017.7342"}], "href": "https://doi.org/10.1089/ars.2017.7342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28899199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28899199"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Ilaria Bellezza, Ileana Giambanco, Alba Minelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf2-Keap1 signaling in oxidative and reductive stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Cell Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2018.02.010"}], "href": "https://doi.org/10.1016/j.bbamcr.2018.02.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29499228"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29499228"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Masayuki Yamamoto, Thomas W Kensler, Hozumi Motohashi "}, {"type": "b", "children": [{"type": "t", "text": "The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Physiol Rev (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/physrev.00023.2017"}], "href": "https://doi.org/10.1152/physrev.00023.2017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29717933"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29717933"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Daiha Shin, Eun Hye Kim, Jaewang Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2018.10.426"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2018.10.426"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30339884"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30339884"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Luca Lignitto, Sarah E LeBoeuf, Harrison Homer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2019.06.003"}], "href": "https://doi.org/10.1016/j.cell.2019.06.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31257023"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31257023"}]}]}]}
|
| Synonyms | HEBP1, IMDDHH |
| Proteins | NF2L2_HUMAN |
| NCBI Gene ID | 4780 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NFE2L2 has 19,275 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 136 datasets.
Click the + buttons to view associations for NFE2L2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by NFE2L2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NFE2L2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NFE2L2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NFE2L2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving NFE2L2 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NFE2L2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NFE2L2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NFE2L2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NFE2L2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with NFE2L2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NFE2L2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NFE2L2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NFE2L2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NFE2L2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with NFE2L2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of NFE2L2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NFE2L2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NFE2L2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing NFE2L2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing NFE2L2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing NFE2L2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NFE2L2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NFE2L2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing NFE2L2 protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NFE2L2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NFE2L2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NFE2L2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NFE2L2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of NFE2L2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NFE2L2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for NFE2L2 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NFE2L2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NFE2L2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NFE2L2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NFE2L2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NFE2L2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NFE2L2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NFE2L2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NFE2L2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NFE2L2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with NFE2L2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with NFE2L2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NFE2L2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NFE2L2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NFE2L2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NFE2L2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NFE2L2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NFE2L2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NFE2L2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NFE2L2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NFE2L2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NFE2L2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NFE2L2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NFE2L2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing NFE2L2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing NFE2L2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NFE2L2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NFE2L2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NFE2L2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NFE2L2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NFE2L2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NFE2L2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NFE2L2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NFE2L2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NFE2L2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for NFE2L2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with NFE2L2 gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with NFE2L2 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with NFE2L2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NFE2L2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by NFE2L2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NFE2L2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NFE2L2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NFE2L2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NFE2L2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate NFE2L2 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving NFE2L2 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving NFE2L2 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate NFE2L2 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate NFE2L2 protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NFE2L2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NFE2L2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NFE2L2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NFE2L2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of NFE2L2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NFE2L2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NFE2L2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NFE2L2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting NFE2L2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NFE2L2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NFE2L2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NFE2L2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NFE2L2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NFE2L2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NFE2L2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NFE2L2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NFE2L2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NFE2L2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NFE2L2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with NFE2L2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate NFE2L2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| Reactome Pathways 2024 | pathways involving NFE2L2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NFE2L2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NFE2L2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NFE2L2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NFE2L2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NFE2L2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NFE2L2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of NFE2L2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NFE2L2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NFE2L2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of NFE2L2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of NFE2L2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of NFE2L2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of NFE2L2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NFE2L2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NFE2L2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NFE2L2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NFE2L2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of NFE2L2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NFE2L2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NFE2L2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NFE2L2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving NFE2L2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving NFE2L2 protein from the WikiPathways Pathways 2024 dataset. | |